An antibody for treating advanced prostate cancer improves progression-free survival in patients with metastasized, castration-resistant prostate cancer. This is the finding of the long-term analyses of an international phase 3 clinical trial. The study showed that overall survival was 2 - 3 times higher than in the placebo arm.
from Top Health News -- ScienceDaily https://ift.tt/36pcpYj
the news of the day, for today, top news of today, world news today live, top local news, top news stories of the day, top news today in the world, news today nyc, top news today local,
Subscribe to:
Post Comments (Atom)
A woman met a group of migrants at a school bus stop. Then the story hit the internet
from Yahoo News - Latest News & Headlines https://ift.tt/nkAV0rJ
-
from Yahoo News - Latest News & Headlines https://ift.tt/m2VMCS1
-
from Yahoo News - Latest News & Headlines https://ift.tt/8VE7G9Y
-
from Yahoo News - Latest News & Headlines https://ift.tt/jYPuwNf
No comments:
Post a Comment